Purdue Pharma L.P. v. IMPAX Laboratories, Inc.
1:13-cv-00763
Overview
Parties
Plaintiff
Counter Defendant
Grunenthal GMBH NPE (Individual / Inventor)
Represented By
6 Attorneys ListedWilk Auslander LLP
1515 Broadway, 43rd Floor, New York, NY 10036
Court & Judges
Court
District Court, S.D. New York (nysd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 8,309,060 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2012025163 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2014010583 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2016007438 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,130,591 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2019002997 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2020018833 | US Continuation / Sibling | View Official Patent → |
| π©πͺ Germany | DE 10336400 | Germany Counterpart | View Official Patent → |
| πΊπΈ United States | US 8,114,383 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8309060
Abuse-proofed dosage form
|
Filed: 2012-01-09
Issued: 2012-11-13
|
Active (5.1 yrs remaining)
Expires: 2032-01-09
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
1
Granted
0
Denied
0
Pending / Review
4
Motions by Category
Key Dispositive Motions & Rulings